Teri L. Lawver - Feb 24, 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Feb 24, 2025
Transactions value $
$0
Form type
4
Date filed
2/26/2025, 06:47 PM
Previous filing
Mar 14, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +69.8K $0.00 69.8K Feb 24, 2025 Common Stock, par value $0.0001 69.8K $6.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following February 24, 2025 subject to the reporting person's continued service through the applicable vesting date.